NEW YORK (GenomeWeb) – Researchers led by the Broad Institute's Feng Zhang have engineered an ortholog of the CRISPR nuclease Cas12b, making its genome editing activity in human cell lines and ex vivo in primary human T cells more robust.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.
The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.
New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.
In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.
This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.
This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.